Tiziana Life Interest Expense Over Time

TLSA Stock  USD 0.95  0.03  3.26%   
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Tiziana Life Performance and Tiziana Life Correlation.
  
As of December 1, 2024, Interest Expense is expected to decline to 9,500.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Tiziana Life. If investors know Tiziana will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Tiziana Life listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.13)
Revenue Per Share
(0.02)
Return On Assets
(0.70)
Return On Equity
(1.81)
The market value of Tiziana Life Sciences is measured differently than its book value, which is the value of Tiziana that is recorded on the company's balance sheet. Investors also form their own opinion of Tiziana Life's value that differs from its market value or its book value, called intrinsic value, which is Tiziana Life's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Tiziana Life's market value can be influenced by many factors that don't directly affect Tiziana Life's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Tiziana Life's value and its price as these two are different measures arrived at by different means. Investors typically determine if Tiziana Life is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Tiziana Life's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Specify up to 10 symbols:

Cross Equities Interest Expense Analysis

Compare Tiziana Life Sciences and related stocks such as Clearmind Medicine Common, Hillstream Biopharma, and Coeptis Therapeutics Interest Expense Over Time
Select Fundamental
Price To Sales RatioPtb Ratio
Days Sales OutstandingBook Value Per Share
Free Cash Flow YieldInvested Capital
Operating Cash Flow Per ShareAverage Payables
Stock Based Compensation To RevenueCapex To Depreciation
Pb RatioEv To Sales
Free Cash Flow Per ShareInventory Turnover
Net Income Per ShareDays Of Inventory On Hand
Sales General And Administrative To RevenueAverage Inventory
Research And Ddevelopement To RevenueCapex To Revenue
Cash Per SharePocfratio
Interest CoveragePayout Ratio
Capex To Operating Cash FlowPfcf Ratio
Days Payables OutstandingNet Current Asset Value
Income QualityTangible Asset Value
Ev To Operating Cash FlowPe Ratio
Ev To Free Cash FlowIntangibles To Total Assets
Net Debt To E B I T D ACurrent Ratio
Tangible Book Value Per ShareGraham Number
Shareholders Equity Per ShareDebt To Equity
Capex Per ShareGraham Net Net
Average ReceivablesRevenue Per Share
Interest Debt Per ShareDebt To Assets
Enterprise Value Over E B I T D ADividend Yield
RoicPayables Turnover
RoeReturn On Tangible Assets
Earnings YieldReceivables Turnover
Short Term Coverage RatiosPrice Earnings Ratio
Price Book Value RatioPrice Earnings To Growth Ratio
Days Of Payables OutstandingDividend Payout Ratio
Price To Operating Cash Flows RatioPrice To Free Cash Flows Ratio
Pretax Profit MarginEbt Per Ebit
Operating Profit MarginEffective Tax Rate
Company Equity MultiplierLong Term Debt To Capitalization
Total Debt To CapitalizationDebt Equity Ratio
Ebit Per RevenueQuick Ratio
Dividend Paid And Capex Coverage RatioNet Income Per E B T
Cash RatioOperating Cash Flow Sales Ratio
Days Of Inventory OutstandingDays Of Sales Outstanding
Free Cash Flow Operating Cash Flow RatioCash Flow Coverage Ratios
Price To Book RatioCapital Expenditure Coverage Ratio
Price Cash Flow RatioEnterprise Value Multiple
Debt RatioCash Flow To Debt Ratio
Price Sales RatioNet Profit Margin
Gross Profit MarginPrice Fair Value
Return On Capital EmployedFixed Asset Turnover
Return On AssetsAsset Turnover
Return On EquityOperating Cycle
Cash Conversion Cycle
201020112012201320142015201620172018201920202021202220232024
CMND0.00.00.00.00.00.00.00.00.00.0446.4 K19.7 K19.7 K22.6 K21.5 K
COEP0.00.00.00.00.00.00.00.00.00.0148.2 K187.1 K218.4 K251.2 K141.6 K
QNRX412.3 K412.3 K412.3 K412.3 K412.3 K412.3 K412.3 K412.3 K412.3 K412.3 K47 K1.1 M714.1 K0.00.0
AFMD3.9 M3.9 M3.9 M10.4 M4.3 M703 K803 K690 K847 K483 K95 K712 K1.6 M1.8 M1.8 M
LPTX0.00.00.00.04.4 M18 K1.2 M121 K19 K23 K39 K41 K54 KK4.8 K
ADAP6.1 K6.1 K6.1 K6.8 K508.2 K508.2 K0.02.2 M376 K2.8 M3.5 M4.9 MM1.2 M1.6 M
CRVS0.00.00.00.00.00.0601 K0.02.3 M2.2 M540 K15 K654 K1.6 M864.5 K
APTO0.014.3 K19.4 K5.8 K238.7 K31 K49.1 K68 K283 K574 K522 K92 K770 K885.5 K929.8 K
BNOXK64.5 K78.2 K609.5 K863.8 K1.9 MM2.1 M2.4 M1.8 M1.2 M26.9 K21.3 K20 K19 K
SPRC25.2 K25.2 K25.2 KK3.3 K1.3 K1.3 KK123 K568 K25 K12 K36 KK8.6 K
BHVN12.7 M12.7 M12.7 M12.7 M12.7 M12.7 M12.7 M12.7 M12.7 M12.7 M41.6 M41.6 M1.4 M1.2 M1.2 M
IMNM141 K141 K141 K141 K141 K141 K141 K141 K141 K106 K38 K10 KK4.5 K4.3 K
INBX0.00.00.00.00.00.00.02.1 M1.5 M5.7 M10.8 M5.2 M16.1 M31.8 M33.4 M

Tiziana Life Sciences and related stocks such as Clearmind Medicine Common, Hillstream Biopharma, and Coeptis Therapeutics Interest Expense description

The cost incurred by an entity for borrowed funds, including loans, bonds, or lines of credit.

My Equities

My Current Equities and Potential Positions

Tiziana Life Sciences
TLSA
Specialization
Health Care, Pharmaceuticals, Biotechnology & Life Sciences
LocationUnited Kingdom
ExchangeNASDAQ Exchange
USD 0.95
When determining whether Tiziana Life Sciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Tiziana Life's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Tiziana Life Sciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Tiziana Life Sciences Stock:
Check out Tiziana Life Performance and Tiziana Life Correlation.
You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Tiziana Life technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Tiziana Life technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Tiziana Life trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...